Microbial metabolites and fibrocyte responses in thyroid-associated ophthalmopathy: emerging mechanisms and therapeutic perspectives

Background Thyroid-associated ophthalmopathy (TAO) is an autoimmune orbital disorder marked by inflammation and tissue remodeling, causing proptosis, diplopia, and visual impairment. While TSHR and IGF-1R signaling in orbital fibroblasts are central to current models, they do not fully explain the heterogeneity of orbital phenotypes in systemic thyroid autoimmunity. Methods This summary interprets recent TAO literature through a fibrocyte-based framework, focusing on evidence linking microbial and metabolic signals to orbital disease. Reviewed findings include ocular surface dysbiosis, altered gut microbiota, fecal metabolite shifts, and metabolite-dependent effects on orbital fibroblast phenotypes, especially those involving short-chain fatty acids, tryptophan metabolites, bile acids, and lipid-related metabolites. Results The emerging evidence suggests that microbial and metabolic factors may modulate the immune-fibrotic process in TAO. Fibrocytes are proposed not as a replacement for resident orbital fibroblasts, but as a systemic immune-metabolic interface influencing orbital remodeling. Among the metabolite classes discussed, short-chain fatty acids and tryptophan metabolites currently have the strongest functional support relevant to TAO. In contrast, bile acids and lipid-related metabolites remain more exploratory. Collectively, the literature supports a potential role for metabolite-fibrocyte coupling in disease activity and tissue remodeling. Conclusions Current evidence is insufficient to support microbiota-based therapies for TAO. However, the field is ready for longitudinal cohort studies, correlation analyses between metabolites and cell phenotypes, and functional perturbation experiments to test whether metabolite-fibrocyte interactions influence disease activity, remodeling, or treatment response.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-11-17
DOI
https://doi.org/10.3389/fendo.2026.2001221
Primary Topic
Ophthalmology and Eye Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Microbial metabolites and fibrocyte responses in thyroid-associated ophthalmopathy: emerging mechanisms and therapeutic perspectives

Wei Tang, Qian Lv, Yongquan Shi, Xingxing Zhang et al.
1 links
Frontiers in Endocrinology
Ophthalmology and Eye Disorders
article

Microbial metabolites and fibrocyte responses in thyroid-associated ophthalmopathy: emerging mechanisms and therapeutic perspectives

Wei Tang, Qian Lv, Yongquan Shi, Xingxing Zhang, Yan Song
article en

Abstract

Background Thyroid-associated ophthalmopathy (TAO) is an autoimmune orbital disorder marked by inflammation and tissue remodeling, causing proptosis, diplopia, and visual impairment. While TSHR and IGF-1R signaling in orbital fibroblasts are central to current models, they do not fully explain the heterogeneity of orbital phenotypes in systemic thyroid autoimmunity. Methods This summary interprets recent TAO literature through a fibrocyte-based framework, focusing on evidence linking microbial and metabolic signals to orbital disease. Reviewed findings include ocular surface dysbiosis, altered gut microbiota, fecal metabolite shifts, and metabolite-dependent effects on orbital fibroblast phenotypes, especially those involving short-chain fatty acids, tryptophan metabolites, bile acids, and lipid-related metabolites. Results The emerging evidence suggests that microbial and metabolic factors may modulate the immune-fibrotic process in TAO. Fibrocytes are proposed not as a replacement for resident orbital fibroblasts, but as a systemic immune-metabolic interface influencing orbital remodeling. Among the metabolite classes discussed, short-chain fatty acids and tryptophan metabolites currently have the strongest functional support relevant to TAO. In contrast, bile acids and lipid-related metabolites remain more exploratory. Collectively, the literature supports a potential role for metabolite-fibrocyte coupling in disease activity and tissue remodeling. Conclusions Current evidence is insufficient to support microbiota-based therapies for TAO. However, the field is ready for longitudinal cohort studies, correlation analyses between metabolites and cell phenotypes, and functional perturbation experiments to test whether metabolite-fibrocyte interactions influence disease activity, remodeling, or treatment response.

Frontiers in EndocrinologyVol. 17
Second Military Medical University (CN), Shanghai Changzheng Hospital (CN)
Good health and well-being
Ophthalmology and Eye Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon